Displaying drugs 10376 - 10400 of 10872 in total
Zoalene
Dinitolmide is a fodder additive for prophylaxis against coccidiosis infections in poultry.
Experimental
Vet approved
Matched Description: … Dinitolmide is a fodder additive for prophylaxis against coccidiosis infections in poultry. …
Liafensine
Liafensine is under investigation in clinical trial NCT00892840 (Multiple-Ascending Dose Study).
Investigational
Matched Iupac: … 6-[(4S)-2-methyl-4-(naphthalen-2-yl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine …
Matched Description: … Liafensine is under investigation in clinical trial NCT00892840 (Multiple-Ascending Dose Study). …
Matched Description: … Liafensine is under investigation in clinical trial NCT00892840 (Multiple-Ascending Dose Study). …
Lunasine
Lunasine is under investigation in clinical trial NCT02709330 (ALS Reversals - Lunasin Regimen).
Investigational
Matched Description: … Lunasine is under investigation in clinical trial NCT02709330 (ALS Reversals - Lunasin Regimen). …
JAK4D
JAK4D is a first-in-class thyrotropin-releasing hormone (TRH)-based compound.
Investigational
Matched Description: … JAK4D is a first-in-class thyrotropin-releasing hormone (TRH)-based compound. …
PF-03382792
Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers).
Investigational
Matched Description: … Drug Levels And Other Biological Effects In Healthy Volunteers). ... Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma …
SLV-334
SLV-334 is under investigation in clinical trial NCT00735085 (A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.).
Investigational
Matched Description: … in Patients With Traumatic Brain Injury.). ... SLV-334 is under investigation in clinical trial NCT00735085 (A Phase 2a Dose Escalation Study With SLV334 …
BGB-DXP593
BGB-DXP593 is a SARS-CoV-2 neutralizing antibody. It is currently being investigated against COVID-19 in the clinical trial NCT04551898 (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)) by BeiGene.
Investigational
Matched Description: … [L27401] It is currently being investigated against COVID-19 in the clinical trial NCT04551898 (Severe ... Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants …
D-Phenylalanine
An essential aromatic amino acid that is a precursor of melanin; dopamine; noradrenalin (norepinephrine), and thyroxine. [PubChem]
Experimental
Matched Description: … An essential aromatic amino acid that is a precursor of melanin; dopamine; noradrenalin (norepinephrine …
Pexacerfont
Pexacerfont has been investigated for the treatment of Alcoholism, Anxiety Disorder, Alcohol Dependence, and Alcohol-Related Disorders.
Investigational
Matched Description: … Pexacerfont has been investigated for the treatment of Alcoholism, Anxiety Disorder, Alcohol Dependence …
RTL-1000
RTL-1000 is a recombinant T-Cell receptor ligand being investigated for the treatment of multiple sclerosis.
Investigational
Matched Description: … RTL-1000 is a recombinant T-Cell receptor ligand being investigated for the treatment of multiple sclerosis …
PYX-201
PYX-201 is an antibody-drug conjugate directed against the extra domain-B splice variant of fibronectin.
Investigational
Matched Description: … PYX-201 is an antibody-drug conjugate directed against the extra domain-B splice variant of fibronectin …
IDUA-RTB
RTB-IDUA is a fusion protein of alpha-L-iduronidase (IDUA) and ricin transport subunit B (RTB).
Investigational
Matched Description: … RTB-IDUA is a fusion protein of alpha-L-iduronidase (IDUA) and ricin transport subunit B (RTB). …
Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid
A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein. [PubChem]
Experimental
Matched Description: … A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside …
Hexoprenaline
Hexoprenaline is a stimulant of beta 2 adrenergic receptors. It is used as a bronchodilator, antiasthmatic, and tocolytic agent.
Experimental
Withdrawn
Matched Description: … Hexoprenaline is a stimulant of beta 2 adrenergic receptors. …
Matched Salts cas: … 32266-10-7 …
Matched Salts cas: … 32266-10-7 …
LTX-109
LTX-109 has been investigated for the treatment of Atopic Dermatitis, Mild Eczema/Dermatoses, and Gram-positive, Skin Infections.
Investigational
Matched Description: … LTX-109 has been investigated for the treatment of Atopic Dermatitis, Mild Eczema/Dermatoses, and Gram-positive …
HH-009
HH-009 is a recombinant human IgG4 monoclonal antibody against FGF19 being studied for the treatment of hepatocellular carcinoma.
Investigational
Matched Description: … HH-009 is a recombinant human IgG4 monoclonal antibody against FGF19 being studied for the treatment of …
JNJ-28330835
A selective androgen receptor modulator with minimal prostate hypertrophic activity, enhances lean body mass in male rats and stimulates sexual behavior in female rats.
Experimental
Matched Description: … male rats and stimulates sexual behavior in female rats. ... selective androgen receptor modulator with minimal prostate hypertrophic activity, enhances lean body mass in …
Nanrilkefusp alfa
Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).
Investigational
Matched Description: … binding sushi+ domain of IL-15 receptor alpha (IL-15Ra). ... Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity …
Bunamiodyl
Withdrawn from the Canadian, US, and UK markets in 1963 due to nephropathy.
Withdrawn
Matched Description: … Withdrawn from the Canadian, US, and UK markets in 1963 due to nephropathy. …
Cortivazol
Cortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection (CHCI)).
Investigational
Matched Iupac: … 2-[(1S,2R,13S,14S,16R,17R,18S,20S)-17,20-dihydroxy-2,11,16,18-tetramethyl-7-phenyl-6,7-diazapentacyclo …
Matched Description: … Cortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection …
Matched Description: … Cortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection …
NPI 32101
NPI 32101 possesses both anti-inflammatory and broad spectrum antimicrobial activities. This combination of pharmacological properties may have additional therapeutic uses beyond dermatology.
Investigational
Matched Description: … This combination of pharmacological properties may have additional therapeutic uses beyond dermatology …
Pepinemab
Pepinemab is under investigation in clinical trial NCT03769155 (VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma).
Investigational
Matched Description: … and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma). ... Pepinemab is under investigation in clinical trial NCT03769155 (VX15/2503 With or Without Ipilimumab …
Birabresib
Birabresib is under investigation in clinical trial NCT02698176 (A Dose Exploration Study With MK-8628 in Participants With Selected Advanced Solid Tumors (MK-8628-006)).
Investigational
Matched Iupac: … 2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0^{2,6}]trideca-2 …
Matched Description: … in Participants With Selected Advanced Solid Tumors (MK-8628-006)). ... Birabresib is under investigation in clinical trial NCT02698176 (A Dose Exploration Study With MK-8628 …
Matched Description: … in Participants With Selected Advanced Solid Tumors (MK-8628-006)). ... Birabresib is under investigation in clinical trial NCT02698176 (A Dose Exploration Study With MK-8628 …
JNJ-27548547
JNJ-27548547 is under investigation in clinical trial NCT01705002 (Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.).
Investigational
Matched Iupac: … bis(octadecanoyloxy)propyl]disulfanyl}phenyl)methyl (4S,6S,7R,8S)-11-amino-8-[(carbamoyloxy)methyl]-7- …
Matched Description: … Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.). ... JNJ-27548547 is under investigation in clinical trial NCT01705002 (Intravenously Administered Pegylated …
Matched Description: … Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.). ... JNJ-27548547 is under investigation in clinical trial NCT01705002 (Intravenously Administered Pegylated …
Isoquercitrin
Isoquercitrin is under investigation in clinical trial NCT04622865 (Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19).
Investigational
Matched Description: … and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19). ... Isoquercitrin is under investigation in clinical trial NCT04622865 (Masitinib Combined With Isoquercetin …
Displaying drugs 10376 - 10400 of 10872 in total